Literature DB >> 22527297

[Pemphigus erythematosus].

P M Amann1, M Megahed.   

Abstract

Pemphigus erythematosus, also known as Senear-Usher syndrome, was originally described as a variant of pemphigus with features of lupus erythematosus but regarded today as a localized form of pemphigus foliaceus and considered an autoimmune bullous disease. The autoantigen is desmoglein 1, a desmosomal adhesion protein in keratinocytes. A 69-year-old man presented with a 3-month history of erosions and blisters on the cheeks, which then also appeared on the trunk. Clinical and histopathologic criteria as well as immunofluorescence studies lead to the diagnosis of pemphigus erythematosus with transition to pemphigus foliaceus.

Entities:  

Mesh:

Year:  2012        PMID: 22527297     DOI: 10.1007/s00105-012-2374-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  8 in total

1.  Control of childhood pemphigus erythematosus with steroids and azathioprine.

Authors:  M T Gupta; H R Jerajani
Journal:  Br J Dermatol       Date:  2004-01       Impact factor: 9.302

2.  Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

Authors:  Michael R Heaphy; Joerg Albrecht; Victoria P Werth
Journal:  Arch Dermatol       Date:  2005-06

Review 3.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

Review 4.  The pathogenic role of autoantibodies in pemphigus vulgaris.

Authors:  M Pan; X Liu; J Zheng
Journal:  Clin Exp Dermatol       Date:  2011-09-09       Impact factor: 3.470

Review 5.  A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus.

Authors:  Linda K Martin; Victoria P Werth; Elmer V Villaneuva; Dédée F Murrell
Journal:  J Am Acad Dermatol       Date:  2011-02-25       Impact factor: 11.527

Review 6.  [Autoimmune bullous skin disorders].

Authors:  Michael Hertl; Andrea Niedermeier; Luca Borradori
Journal:  Ther Umsch       Date:  2010-09

7.  The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.

Authors:  M Amagai; K Tsunoda; D Zillikens; T Nagai; T Nishikawa
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

8.  Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris.

Authors:  M Behzad; C Möbs; A Kneisel; M Möller; J Hoyer; M Hertl; R Eming
Journal:  Br J Dermatol       Date:  2012-04       Impact factor: 9.302

  8 in total
  1 in total

1.  Pemphigus foliaceus presenting with violaceous, painful nodules and an aberrant auto-antibody expression in a Latino patient.

Authors:  Jeffrey N Li; Parth Patel; Cristian Gonzalez; Travis Vandergriff; Heather Goff
Journal:  JAAD Case Rep       Date:  2021-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.